October 7, 2009 – Rates of death were similar in patients with and without incidental findings (IF) identified with cardiac computed tomography (CT), and IF was not an independent predictor of noncardiac death, reported researchers in a study published in the online version of the October 2009 issues of the Journal of the American College of Cardiology.

October 6, 2009 – Siemens Healthcare announced the availability of syngo Dynamic PET with myocardial blood flow, a new cardiac imaging software application for the industry-leading Biograph PET/CT scanners that may have significant impact on the diagnosis of patients with advanced coronary artery disease (CAD) and specifically, with those patients with multivessel disease, or those who are asymp

October 6, 2009 – The Harvard Clinical Research Institute (HCRI) said last week the first patients are enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual anti-platelet therapy (DAPT, the combination of aspirin and a thienopyridine/anti-platelet medication to reduce the risk of blood clots) following drug-eluting stent i

October 6, 2009 - Boston Scientific Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures.

October 6, 2009 – Direct Flow Medical Inc. released its One-year data from the initial clinical trial for its transcatheter prosthetic aortic valve during the recent Transcatheter Cardiovascular Therapeutics (TCT) 2009 meeting .

October 6, 2009 – New research shows magnetic interference from portable headphones has a clinically significant impact on the function of life-saving devices, according to a new study published in the October edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.

October 6, 2009 – ProSolv CardioVascular, a Fujifilm company, recently said the Veterans in Partnership Healthcare Network (VISN 11) has extended its relationship with the company by contracting to add the Synapse ProSolv Cardiovascular solution in four additional hospitals.

October 6, 2009 – Boston Scientific Corp. released data during TCT 2009 from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberté Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

The AMICAS One Suite of products provides a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support and scalable design. The suite includes the following tools:

October 5, 2009 – The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has awarded a grant to the American College of Cardiology (ACC) in partnership with the Society of Thoracic Surgeons (STS) to study the comparative effectiveness of the two forms of coronary revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass graft (CAB

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now